Skip to main content
. 2018 Aug 23;30(12):e13454. doi: 10.1111/nmo.13454

Figure 6.

Figure 6

Fecal pellet transit in WT and PYY‐/‐ mouse colon in vitro, in vehicle controls (0.1% DMSO in A & B; H2O in C & D), or FFA2 agonist PA (1 µ mol L−1, +PA), FFA3 agonist AR420626 (1 µ mol L−1, +AR), or, in C & D, propionate (+Prop; 5 m mol L−1)‐treated tissue. Values are the mean + 1SEM (from numbers shown in parentheses) with statistical differences between drug‐treated and control groups as shown (*≤ 0.05)